[D-penicillamine in the treatment of patients with rheumatoid arthritis]. 1983

G V Gracheva, and N K Erov, and L R Romanovskaia

UI MeSH Term Description Entries
D007841 Latex Fixation Tests Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed) Latex Agglutination Tests,Agglutination Test, Latex,Agglutination Tests, Latex,Fixation Test, Latex,Fixation Tests, Latex,Latex Agglutination Test,Latex Fixation Test,Test, Latex Agglutination,Test, Latex Fixation,Tests, Latex Agglutination,Tests, Latex Fixation
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

G V Gracheva, and N K Erov, and L R Romanovskaia
December 1978, The Nebraska medical journal,
G V Gracheva, and N K Erov, and L R Romanovskaia
November 1971, Arzneimittel-Forschung,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1975, Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1972, Reumatologia,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1975, Terapevticheskii arkhiv,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1977, Reumatismo,
G V Gracheva, and N K Erov, and L R Romanovskaia
December 1979, Minnesota medicine,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1980, Voprosy revmatizma,
G V Gracheva, and N K Erov, and L R Romanovskaia
March 1977, Arthritis and rheumatism,
G V Gracheva, and N K Erov, and L R Romanovskaia
January 1977, Godisen zbornik na Medicinskiot fakultet vo Skopje,
Copied contents to your clipboard!